Skip to content

Insider · CIK 0001590794

Janet S. Vergis

director

Files at CHD (CHURCH & DWIGHT CO INC /DE/), XRAY (DENTSPLY SIRONA Inc.), TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jul 11, 2025XRAY
DENTSPLY SIRONA Inc.
AGrant or award
Common Stock
+139$0.00$044,121Jul 15, 2025
Jun 30, 2025CHD
CHURCH & DWIGHT CO INC /DE/
AGrant or award
Common Stock
+729$96.11$70k17,102Jul 8, 2025
Jun 6, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
MOption exercise
Ordinary Shares
+9,632--73,697Jun 9, 2025
Jun 6, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
MOption exercise
Restricted Share Unitsderivative
-9,632$0.00$00Jun 9, 2025
Jun 5, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
AGrant or award
Restricted Share Unitsderivative
+14,492$0.00$014,492Jun 9, 2025
May 22, 2025XRAY
DENTSPLY SIRONA Inc.
AGrant or award
Common Stock
+13,880$0.00$043,981May 27, 2025
May 2, 2025CHD
CHURCH & DWIGHT CO INC /DE/
AGrant or award
Common Stock
+860$0.00$0860May 6, 2025
May 2, 2025CHD
CHURCH & DWIGHT CO INC /DE/
AGrant or award
Stock Option (right to buy)derivative
+2,890$0.00$02,890May 6, 2025
Apr 11, 2025XRAY
DENTSPLY SIRONA Inc.
AGrant or award
Common Stock
+87$0.00$030,101Apr 15, 2025
Jan 10, 2025XRAY
DENTSPLY SIRONA Inc.
AGrant or award
Common Stock
+68$0.00$030,014Jan 14, 2025
Oct 11, 2024XRAY
DENTSPLY SIRONA Inc.
AGrant or award
Common Stock
+48$0.00$029,945Oct 15, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Janet S. Vergis: insider trades and track record | InsiderTell